migratory necrolytic erythema; glucagonoma syndrome; erythema necrolytica migrans

From Aaushi
Jump to navigation Jump to search

Etiology

* rare patients without underlying malignancy[2]

Epidemiology

  • rare
  • middle-aged to elderly

Pathology

Clinical manifestations

Laboratory

Differential diagnosis

Management

  • responds poorly to all forms of therapy
  • partial response in some cases to zinc replacement
  • surgical excision of glucagonoma may improve or resolve symptoms

More general terms

References

  1. Color Atlas & Synopsis of Clinical Dermatology, Common & Serious Diseases, 3rd ed, Fitzpatrick et al, McGraw Hill, NY, 1997, pg 512
  2. Jump up to: 2.0 2.1 2.2 Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18. American College of Physicians, Philadelphia 2012, 2015, 2018.